CINQAIR.com – CINQAIR® (reslizumab) Injection now approved

- tevarespiratorybiologics.com

CINQAIR® (reslizumab) Injection is now approved as an add-on treatment for adults (18 years and older) with severe asthma and elevated eosinophil levels

  Not Applicable   $ 0.00